Healthpeak Properties, Inc. $DOC Shares Sold by Cullen Capital Management LLC

Cullen Capital Management LLC decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 9,247,344 shares of the real estate investment trust’s stock after selling 985,531 shares during the quarter. Healthpeak Properties comprises approximately 1.6% of Cullen Capital Management LLC’s investment portfolio, making the stock its 23rd largest holding. Cullen Capital Management LLC’s holdings in Healthpeak Properties were worth $148,697,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of DOC. Norges Bank acquired a new position in shares of Healthpeak Properties in the fourth quarter worth about $153,550,000. JPMorgan Chase & Co. lifted its stake in shares of Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after acquiring an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in shares of Healthpeak Properties by 42.7% in the fourth quarter. Bank of New York Mellon Corp now owns 9,641,231 shares of the real estate investment trust’s stock worth $155,031,000 after acquiring an additional 2,887,084 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.7%

Shares of NYSE DOC opened at $20.64 on Friday. The stock’s 50 day moving average price is $18.34 and its two-hundred day moving average price is $17.49. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $20.82. The stock has a market capitalization of $14.23 billion, a P/E ratio of 64.51, a PEG ratio of 3.21 and a beta of 1.05. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, analysts anticipate that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Analysts Set New Price Targets

DOC has been the topic of several research reports. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Scotiabank upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Wednesday, May 27th. Citigroup upped their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Royal Bank Of Canada upped their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Thursday, May 14th. Finally, Robert W. Baird upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $19.54.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.23% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.